Breaking Finance News

Zacks Investment Research downgraded Torchmark Corporation (NYSE:TMK) to Hold in a report released today.

Yesterday Torchmark Corporation (NYSE:TMK) traded 0.38% higher at $77.47. The company’s 50-day moving average is $77.65 and its 200-day moving average is $76.97. The last stock close price is up 0.33% from the 200-day moving average, compared to the S&P 500 which has increased 0.04% over the same time. 658,241 shares of the stock were exchanged, up from an average trading volume of 418,045

Zacks Investment Research has downgraded Torchmark Corporation (NYSE:TMK) to Hold in a report released on 6/21/2017.

Previously on 06/19/2017, Zacks Investment Research reported about Torchmark Corporation (NYSE:TMK) raised the target price from $0.00 to $87.00. At the time, this indicated a possible upside of 0.13%.

See Chart Below

Torchmark Corporation (NYSE:TMK)

Torchmark Corporation has a 52 week low of $62.86 and a 52 week high of $79.90 with a P/E ratio of 16.61 The company’s market cap is currently $0.

About Torchmark Corporation (NYSE:TMK)

Torchmark Corporation (Torchmark) is an insurance holding company. The Company, through its subsidiaries, provides a range of life and health insurance products and annuities to a base of customers. The Company's segments include life insurance, health insurance, annuities and investment. The life insurance segment includes traditional and interest-sensitive whole life insurance as well as term life insurance. The Health insurance products are guaranteed-renewable and include Medicare Supplement, critical illness, accident and limited-benefit supplemental hospital and surgical coverage's. Annuities include fixed-benefit contracts. The Company markets its insurance products through various distribution channels, each of which sells the products of its insurance segments. Its subsidiaries include American Income Life Insurance Company (American Income) and Liberty National Life Insurance Company (Liberty National).

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with MarketBeat.com's FREE daily email newsletter.

Leave a Reply

Your email address will not be published. Required fields are marked *